Moleculin Biotech MBRX Balance Sheet (2015-2026)

NASDAQ MBRX
$0.53 -0.04 (-7.49%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Moleculin Biotech Quarterly Balance Sheet

Periods 42 quarters
Latest Jun 2026

Moleculin Biotech reported total assets of $21.09M and total liabilities of $9.50M for the quarter ended Jun 2026, up 0.4% year over year. This balance sheet covers 42 quarters of results from Dec 2015 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
79.51M75.20M70.90M66.10M58.00M50.40M43.15M37.30M32.20M24.60M23.55M16.82M10.85M9.40M4.28M7.72M7.56M6.70M8.88M7.26M
Receivables - NetNet Receivables
0.02M0.01M
Receivables - OtherOther Receivables
0.02M0.02M0.03M0.01M0.00M0.01M0.10M0.01M0.02M0.00M0.00M0.00M0.01M0.00M
Receivables
0.02M0.01M
Prepaid Assets
2.33M1.89M1.59M1.16M3.32M3.10M2.45M2.02M3.21M3.02M2.72M2.13M2.89M2.20M0.92M1.62M1.52M1.18M0.81M1.46M
Current Assets
81.84M77.07M72.50M67.26M61.32M53.49M45.60M39.29M35.38M27.60M26.27M18.96M13.73M11.61M5.19M9.34M9.08M7.88M9.69M8.72M
Non-Current Assets
Property, Plant & Equipment (Net)
0.40M0.35M0.34M0.31M0.34M0.31M0.28M0.24M0.23M0.23M0.27M0.24M0.22M0.19M0.16M0.13M0.10M0.08M0.08M0.06M
Goodwill & Intangibles
11.15M11.15M11.15M11.15M11.15M11.15M11.15M11.15M11.15M11.15M11.15M11.15M11.15M11.15M11.15M11.15M11.15M11.15M11.15M11.15M
Other Non-Current Assets
0.90M0.90M0.90M0.90M
Non-Current Assets
11.70M11.63M11.59M11.54M11.93M11.88M11.83M11.77M11.73M11.92M11.94M11.89M11.84M11.79M11.73M11.67M12.52M12.47M12.44M12.36M
Assets
93.53M88.70M84.09M78.80M73.25M65.37M57.42M51.06M47.12M39.52M38.22M30.84M25.57M23.39M16.93M21.01M21.59M20.35M22.13M21.09M
Liabilities
Current Liabilities
Accounts Payables
1.50M1.39M1.36M2.22M3.18M3.57M2.10M1.94M4.14M2.01M2.50M2.10M2.83M2.55M2.03M2.71M3.72M2.12M3.51M4.34M
Notes Payables
Payables
1.50M1.39M1.36M2.22M3.18M3.57M2.10M1.94M4.14M2.01M2.50M2.10M2.83M2.55M2.03M2.71M3.72M2.12M3.51M4.34M
Accumulated Expenses
1.84M2.27M2.26M2.61M2.67M2.79M2.72M3.09M2.42M1.88M4.32M3.30M2.91M3.04M3.33M4.19M4.19M3.57M3.35M4.98M
Other Accumulated Expenses
Total Current Liabilities
3.35M3.66M3.62M4.83M5.86M6.36M4.82M5.03M6.55M3.89M6.82M5.41M5.75M5.59M5.36M6.90M7.91M5.68M6.85M9.31M
Non-Current Liabilities
Operating Leases
0.09M0.07M0.06M0.05M0.39M0.36M0.34M0.31M0.29M0.50M0.47M0.45M0.42M0.39M0.36M0.33M0.29M0.26M0.22M0.15M
Other Non-Current Liabilities
5.39M3.71M1.41M1.25M0.65M0.23M0.08M0.04M0.00M0.00M4.86M3.40M1.70M9.93M16.97M41.33M0.04M0.04M
Total Non-Current Liabilities
3.44M3.73M3.69M4.88M6.25M6.73M5.15M5.34M6.84M4.38M2.43M2.46M4.46M-3.95M5.72M7.22M4.62M5.94M7.08M9.46M
Total Liabilities
8.83M7.44M5.10M6.14M6.90M6.96M5.23M5.38M6.85M4.38M7.29M5.86M6.17M5.98M5.72M7.22M21.60M47.27M7.12M9.50M
Shareholder's Equity
Total Debt
Common Equity
84.70M81.26M78.99M72.67M66.36M58.42M52.19M45.68M40.27M35.14M30.93M24.99M19.41M17.41M11.21M13.79M-0.00M-26.92M15.01M11.59M
Liabilities and Shareholders Equity
93.53M88.70M84.09M78.80M73.25M65.37M57.42M51.06M47.12M39.52M38.22M30.84M25.57M23.39M16.93M21.01M21.59M20.35M22.13M21.09M
Retained Earnings
-65.61M-70.00M-72.81M-79.70M-86.50M-95.10M-101.83M-109.80M-115.73M-121.33M-131.60M-136.60M-140.90M-151.50M-172.44M-178.35M-196.16M-221.60M-206.00M-226.50M

Moleculin Biotech Balance Sheet API

Pull Moleculin Biotech's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=MBRX&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY